FARE Announces Publication of Two Landmark Food Allergy Studies in the Peer-Reviewed “Journal of Allergy and Clinical Immunology: In Practice”

McLEAN, Va.—FARE (Food Allergy Research & Education) today announced that two important research articles have been published in the peer-reviewed Journal of Allergy and Clinical Immunology: In Practice. The two studies drew on different FARE resources, one using the FARE Patient Registry while the other leveraged the FARE Clinical Network, both established to help researchers better understand food allergy and identify new approaches to prevention, diagnosis, and treatment. These two publications reflect that infrastructure in use, translating data into peer-reviewed findings that inform clinical care.  

Both research articles were published online earlier this month with print publication to follow in the coming weeks. 

“Research doesn’t happen in isolation—it depends on the infrastructure, partnerships and participation that make discovery possible,” said Sung Poblete PhD, RN, CEO of FARE. “For years, families managing seed, spice and herb allergies had almost no research to turn to, even though these reactions can be as severe as those from more studied allergens.”

Dr. Poblete continued, “As more centers offer oral immunotherapy without a shared standard for how it’s done, we’re seeing why consistency in patient selection, dosing, and monitoring matters as much as access itself. Both studies demonstrate the importance of creating and funding the right infrastructure to support food allergy research. We’re grateful to our donors for the support that enables these important milestones.”

“Seeds, Spices-Not Always so Nice” draws on data from the FARE Patient Registry to describe the largest cohort of patients (2,601 participants) allergic to sesame, non-sesame-seeds, and herbs/spices, making it a landmark descriptive study in this area. Filling a major knowledge gap in food allergy research, the findings establish foundational evidence of these allergies which have received little scientific attention but can cause severe reactions and significantly affect quality of life. 

“Food Oral Immunotherapy Patient Selection, Dosing, and Monitoring Practices Among a Network of US Food Allergy Centers” was conducted within the FARE Clinical Network and provides one of the first national snapshots of real-world oral immunotherapy practices across leading U.S. food allergy centers, revealing significant variation in patient selection, dosing, and monitoring despite widespread adoption. Its findings identify opportunities to standardize care, improve equitable access, and inform future clinical guidelines.

The FARE Patient Registry is a secure database of health information collected through patient surveys for use within the research community. To date, it has been the primary data source for more than a dozen peer-reviewed articles. The OIT study is the first to utilize the FARE Clinical Network, a coalition of academic, research, and clinical food allergy centers created to ensure that patients with food allergy have access to state-of-the-art diagnosis and treatment, short-term and long-term care, and expand patient access to research opportunities. 

For more information about FARE and its focus on research, visit www.foodallergy.org/research.